References
- Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. hit J Cancer 1988;41: 184–97.
- Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996;56:2556–60.
- Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 1998;90:1529–36.
- Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part II). J Natl Cancer Inst 1998;90:1609–20.
- Herschman HR. Prostaglandin synthase 2. Biochem Biophys Acta 1996;1299:125–40.
- Tsujfi M, DuBois RN. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493–501.
- Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carci-nogenesis. Biochim Biophys Acta 2000;1470:M69–78.
- Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-superfamily member that has proapoptotic and anti-tumorigenic activities. Mol Pharmacol 2001;59:901–8.
- Kim SY, Chu KC, Lee HR, Lee KS, Carey TE. Establish-ment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol (Stockh) 1997;117:775–84.
- Zhang X, Shan P, Sasidhar M, Chupp GL, Flavell RA, Choi AM, et al. Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase med-iate hyperoxia-induced cell death in lung epithelium. Am J Respir Cell Mol Biol 2003;28:305–15.
- Kim KH, Seong BL. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhance-ment of death-inducing signal. EMBO J 2003;9:2104–16.
- Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells. Cancer Res 2003;63:616–20.
- Rice PL, Goldberg RJ, Ray EC, Driggers LJ, Ahnen DJ. Inhibition of extracellular signal-regulated kinase 1/2 phos-phorylation and induction of apoptosis by sulindac metabo-lites. Cancer Res 2001;61: 1541–7.
- Soh JW, Mao Y, Kim MG, Pamukcu R, Li H, Piazza GA, et al. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Chin Cancer Res 2000;6:4136–41.
- Kim GS, Hong JS, Kim SW, Koh JM, An CS, Choi JY, et al. Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem 2003;278:21920–9.
- Liu JJ, Wang JY, Hertervig E, Nilsson A, Duan RD. Sulindac induces apoptosis, inhibits proliferation and activates cas-pase-3 in Hep G2 cells. Anticancer Res 2002;22: 263–6.
- Sun Y, Tang X1\4, Half E, Kuo MT, Sinicrope FA. Cyclooxygenase-2 overexpression reduces apoptotic suscept-ibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 2002;62: 6323–8.
- Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 1998;18: 1946–55.
- Moon EY, Lerner A. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. Cancer Res 2002;62:5711–9.
- Kim KS, Baek SJ, Flake GP, Loftin CD, Calvo BF, Eling TE. Expression and regulation of nonsteroidal anti-inflam-matory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 2002;122:1388–98.